Richard J. Hawkins

Mr. Hawkins has served as a member of Savara’s Board of Directors since October 2010. Mr. Hawkins currently serves on the Board of Directors of several privately held life sciences companies, as well as Plus Therapeutics Inc. (formerly Cytori Therapeutics, Inc.) and previously served on the Board of Directors of SciClone Pharmaceuticals, Inc. until its acquisition in 2017. Mr. Hawkins served as Chief Executive Officer and Chair of the Board of Directors of Lumos Pharma, Inc., a clinical stage biotechnology company focused on bringing novel therapies to patients with severe, rare, and genetic diseases, whose medical needs are unmet, from 2010 until its acquisition in 2024. Prior to his tenure with Lumos Pharma, Inc., Mr. Hawkins founded and advised numerous pharmaceutical companies, including Sensus, where he served as Co-Founder and Chair of the Board of Directors until it was sold to Pfizer. Previously, he was Founder, President, and Chief Executive Officer of Pharmaco, where he guided the company’s growth to more than 2,000 employees. The company later merged with PPD to form PPD Pharmaco, one of the largest clinical contract research organizations in the world. Mr. Hawkins holds a B.S. in Biology from Ohio University.